• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肿瘤中p53突变谱的位置和碱基对特异性比较:阐明癌症病因学中各器官之间的关系。

Position- and base pair-specific comparison of p53 mutation spectra in human tumors: elucidation of relationships between organs for cancer etiology.

作者信息

Lutz W K, Fekete T, Vamvakas S

机构信息

Department of Toxicology, University of Würzburg, Germany.

出版信息

Environ Health Perspect. 1998 Apr;106(4):207-11. doi: 10.1289/ehp.98106207.

DOI:10.1289/ehp.98106207
PMID:9494124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1532972/
Abstract

A new approach to analyze the p53 mutation database of the European Molecular Biology Laboratory for a comparison of mutation spectra is described, with the aim of investigating organ specificity of etiological factors and putative organ-to-organ relationships in cancer pathogenesis. The number of entries of each nucleotide- and base-pair substitution-specific mutation was divided by the total number of tumors analyzed. For each organ pair, the difference of the mutation-specific frequency differences was calculated. Resulting values could range from 0 (full concordance) to 2 (full discordance). Skin, lung, and urinary bladder showed highly independent mutation spectra (maximum discordance value = 1.48 for skin versus brain), in agreement with the presence of specific factors responsible for a large number of the respective tumors (UV light, smoking, aromatic amines). The three organs with the smallest sum of discordance values were mammary gland (breast), colon and esophagus. The minimum organ-to-organ discordance value was 0.95, for stomach versus colon. For these organs, common, possibly also endogenous, cancer risk factors could be postulated as contributing to the observed mutation spectrum. The remaining cancers (ovary, sarcoma, leukemia/lymphoma, brain, head and neck, and stomach, in order or increasing discordance) were of intermediate range and showed a mix of values. Reasons for close relationship to some of the other organs and marked differences to others are discussed. Exclusion of the "hot-spot" mutations did not markedly alter the observed relationships, indicating that a putative selective growth advantage does not cover up the etiological basis for the observed mutation spectrum. It is expected that much more insight into carcinogenesis and cancer could be gained by further exploratory analyses of mutation databases.

摘要

本文描述了一种分析欧洲分子生物学实验室p53突变数据库以比较突变谱的新方法,目的是研究病因学因素的器官特异性以及癌症发病机制中假定的器官间关系。将每个核苷酸和碱基对替换特异性突变的条目数除以分析的肿瘤总数。对于每对器官,计算突变特异性频率差异的差值。所得值的范围可以从0(完全一致)到2(完全不一致)。皮肤、肺和膀胱显示出高度独立的突变谱(皮肤与脑的最大不一致值 = 1.48),这与导致大量相应肿瘤的特定因素(紫外线、吸烟、芳香胺)的存在一致。不一致值总和最小的三个器官是乳腺(乳房)、结肠和食管。胃与结肠的器官间最小不一致值为0.95。对于这些器官,可以假定存在共同的、可能也是内源性的癌症风险因素导致了观察到的突变谱。其余癌症(卵巢、肉瘤、白血病/淋巴瘤、脑、头颈部和胃,按不一致程度递增排序)处于中间范围,且显示出混合值。文中讨论了与其他一些器官密切相关以及与其他器官有显著差异的原因。排除“热点”突变并没有明显改变观察到的关系,这表明假定的选择性生长优势并未掩盖观察到的突变谱的病因基础。预计通过对突变数据库进行进一步的探索性分析,可以更深入地了解致癌作用和癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ec/1532972/6db844b94e3c/envhper00527-0063-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ec/1532972/126287142e9e/envhper00527-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ec/1532972/6db844b94e3c/envhper00527-0063-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ec/1532972/126287142e9e/envhper00527-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30ec/1532972/6db844b94e3c/envhper00527-0063-a.jpg

相似文献

1
Position- and base pair-specific comparison of p53 mutation spectra in human tumors: elucidation of relationships between organs for cancer etiology.人类肿瘤中p53突变谱的位置和碱基对特异性比较:阐明癌症病因学中各器官之间的关系。
Environ Health Perspect. 1998 Apr;106(4):207-11. doi: 10.1289/ehp.98106207.
2
P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.P53突变与乳腺癌、结直肠癌、肝癌、肺癌和卵巢癌相关。
Environ Health Perspect. 1996 Dec;104(12):1324-31. doi: 10.1289/ehp.961041324.
3
p53 mutations in breast cancer.乳腺癌中的p53突变
Cancer Res. 1992 Oct 1;52(19):5291-8.
4
A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.吸烟者肺癌中特定的p53基因突变谱:对国际癌症研究机构(IARC)p53数据库中汇编的突变的综述。
Environ Health Perspect. 1998 Jul;106(7):385-91. doi: 10.1289/ehp.98106385.
5
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
6
p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.p53肿瘤抑制基因:处于分子致癌作用、分子流行病学及癌症风险评估的交叉点上
Environ Health Perspect. 1996 May;104 Suppl 3(Suppl 3):435-9. doi: 10.1289/ehp.96104s3435.
7
Organ specificity of the bladder carcinogen 4-aminobiphenyl in inducing DNA damage and mutation in mice.膀胱致癌物 4-氨基联苯在诱导小鼠 DNA 损伤和突变中的器官特异性。
Cancer Prev Res (Phila). 2012 Feb;5(2):299-308. doi: 10.1158/1940-6207.CAPR-11-0309. Epub 2011 Nov 15.
8
Comparison of induced and cancer-associated mutational spectra using multivariate data analysis.使用多变量数据分析比较诱导突变谱和癌症相关突变谱。
Carcinogenesis. 2008 Apr;29(4):772-8. doi: 10.1093/carcin/bgn053. Epub 2008 Feb 22.
9
IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.国际癌症研究机构p53突变数据库:用于汇编和分析人类肿瘤及细胞系中p53突变的关系型数据库。国际癌症研究机构。
Hum Mutat. 1999;14(1):1-8. doi: 10.1002/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H.
10
Tumors associated with p53 germline mutations: a synopsis of 91 families.与p53种系突变相关的肿瘤:91个家系的概述
Am J Pathol. 1997 Jan;150(1):1-13.

本文引用的文献

1
P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.P53突变与乳腺癌、结直肠癌、肝癌、肺癌和卵巢癌相关。
Environ Health Perspect. 1996 Dec;104(12):1324-31. doi: 10.1289/ehp.961041324.
2
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.人类肿瘤和细胞系中p53基因体细胞突变数据库:最新汇编与未来展望
Nucleic Acids Res. 1997 Jan 1;25(1):151-7. doi: 10.1093/nar/25.1.151.
3
Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.
苯并[a]芘加合物在P53基因肺癌突变热点处的优先形成。
Science. 1996 Oct 18;274(5286):430-2. doi: 10.1126/science.274.5286.430.
4
Cigarette smoking and p53 mutations in lung cancer and bladder cancer.肺癌和膀胱癌中的吸烟与p53突变
Environ Health Perspect. 1996 May;104 Suppl 3(Suppl 3):553-6. doi: 10.1289/ehp.96104s3553.
5
Breast cancer and environmental risk factors: epidemiological and experimental findings.乳腺癌与环境风险因素:流行病学及实验研究结果
Annu Rev Pharmacol Toxicol. 1996;36:573-96. doi: 10.1146/annurev.pa.36.040196.003041.
6
Endogenous and exogenous factors in carcinogenesis: limits to cancer prevention.致癌作用中的内源性和外源性因素:癌症预防的局限性。
Int Arch Occup Environ Health. 1996;68(2):120-5. doi: 10.1007/BF00381244.
7
The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung.烟草特异性N-亚硝胺的生物学意义:吸烟与肺腺癌
Crit Rev Toxicol. 1996;26(2):199-211. doi: 10.3109/10408449609017931.
8
Etiology of cancer in humans and animals.
Exp Toxicol Pathol. 1996 Feb;48(2-3):95-100. doi: 10.1016/S0940-2993(96)80029-7.
9
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation.人类肿瘤和细胞系中p53基因的体细胞点突变:最新汇编。
Nucleic Acids Res. 1996 Jan 1;24(1):141-6. doi: 10.1093/nar/24.1.141.
10
Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.膀胱癌中p53突变的独特模式:与烟草使用的关系。
Cancer Res. 1993 Mar 1;53(5):1162-6.